vanadates has been researched along with Multiple Myeloma in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, F; Rajendran, P; Sethi, G | 1 |
Ahn, KS; Jeong, SJ; Kim, DH; Kim, M; Kim, SH; Lee, EO; Lee, HJ; Park, S; Song, HS | 1 |
Ericson, SG; Yao, Y; Zhou, Q | 1 |
Amiot, M; Bataille, R; Descamps, G; Pellat-Deceunynck, C; Robillard, N; Szpak, Y | 1 |
Larbolette, O; Reth, M; Wienands, J | 1 |
Fujii, R; Ishikawa, H; Kawano, MM; Mahmoud, MS | 1 |
6 other study(ies) available for vanadates and Multiple Myeloma
Article | Year |
---|---|
Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway.
Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Humans; Inositol Polyphosphate 5-Phosphatases; Interleukin-6; Janus Kinase 2; Multiple Myeloma; Phosphoric Monoester Hydrolases; Phosphorylation; Pyrazines; Signal Transduction; STAT3 Transcription Factor; Thalidomide; Vanadates | 2010 |
Inhibition of JAK1/STAT3 signaling mediates compound K-induced apoptosis in human multiple myeloma U266 cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Survival; Down-Regulation; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Ginsenosides; Humans; Janus Kinase 1; Multiple Myeloma; Panax; Poly(ADP-ribose) Polymerases; Protein Tyrosine Phosphatases; Signal Transduction; STAT3 Transcription Factor; Vanadates | 2011 |
The protein tyrosine phosphatase CD45 is required for interleukin 6 signaling in U266 myeloma cells.
Topics: Actins; Antigens, CD; Cell Adhesion; Cell Division; Cell Line, Tumor; Cell Separation; Coculture Techniques; Cytokine Receptor gp130; DNA-Binding Proteins; Humans; Interleukin-6; Leukocyte Common Antigens; Membrane Glycoproteins; Multiple Myeloma; Neoplasm Proteins; Phosphorylation; Phosphotyrosine; Protein Processing, Post-Translational; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor; Stromal Cells; Trans-Activators; Vanadates | 2004 |
The magnitude of Akt/phosphatidylinositol 3'-kinase proliferating signaling is related to CD45 expression in human myeloma cells.
Topics: Androstadienes; Cell Division; Cell Line, Tumor; G1 Phase; Humans; Insulin-Like Growth Factor I; Leukocyte Common Antigens; Multiple Myeloma; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Signal Transduction; Vanadates; Wortmannin | 2004 |
Evidence for a preformed transducer complex organized by the B cell antigen receptor.
Topics: Animals; Cell Line; Enzyme Inhibitors; Glycosylphosphatidylinositols; Hydrogen Peroxide; Immunoglobulin D; Immunoglobulin M; Kinetics; Multiple Myeloma; Phosphoproteins; Phosphorylation; Point Mutation; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Receptors, Antigen, B-Cell; Recombinant Proteins; Signal Transduction; Vanadates | 1996 |
Induction of CD45 expression and proliferation in U-266 myeloma cell line by interleukin-6.
Topics: Antigens, Neoplasm; Cell Division; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; Leukocyte Common Antigens; Multiple Myeloma; Neoplasm Proteins; Neoplastic Stem Cells; Okadaic Acid; Phosphoprotein Phosphatases; Protein Tyrosine Phosphatases; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Vanadates | 1998 |